Furthermore, deletion of AQP4 in APP/PS1 mice has been shown to potentiate the development of amyloid-β pathology and memory deficits (Xu et al., 2015), suggesting that supressed glymphatic clearance is capable of inducing and/or advancing Alzheimer’s disease pathology. This evidence concerns the gene AQP4 and Alzheimer disease.